Effector mechanisms in low-dose streptozotocin-induced diabetes

ML Lukic, S Stošic-Grujicic, A Shahin - Journal of Immunology …, 1998 - hindawi.com
ML Lukic, S Stošic-Grujicic, A Shahin
Journal of Immunology Research, 1998hindawi.com
The cellular and molecular requirements for β-cell damages in an immune-mediated
toxininduced insulin-dependent diabetes mellitus have been studied in the model of multiple
low-dose streptozotocin-induced diabetes in rats and mice. It was found that strain-related
susceptibility to diabetes induction correlated with a higher level of IL-2, IFN-γ, and TNF-α
production, whereas such differences were not observed when IL-1 and NO production by
macrophages were analyzed; elimination of immunoregulatory RT6+ T cells that increases …
The cellular and molecular requirements for β-cell damages in an immune-mediated toxininduced insulin-dependent diabetes mellitus have been studied in the model of multiple low-dose streptozotocin-induced diabetes in rats and mice. It was found that strain-related susceptibility to diabetes induction correlated with a higher level of IL-2, IFN-γ, and TNF-α production, whereas such differences were not observed when IL-1 and NO production by macrophages were analyzed; elimination of immunoregulatory RT6+T cells that increases IFN-γ production, enhances susceptibility to MLD-STZ-induced diabetes; mercury-induced Th-2 cells downregulated the disease; IFN-γ-mediated macrophage activation to produce proinflammatory cytokines rather than NO is an important event in early diabetogenic effects of invading macrophages; inhibition of IL-1 activity downregulates diabetes induction; and generation of NO in β cells appears to be important for diabetogenic effects. Taken together, data indicate that MLD-STZ diabetes is induced by Th-1 lymphocytes that secrete soluble effector molecules that activate macrophages and promote destruction of β cells possibly by both nitric oxide and nonnitric oxide-mediated mechanisms.
hindawi.com